Malaysia pushes Asean to boost self-sufficiency in essential medicines

Malaysia is championing a push for greater pharmaceutical self-reliance across Asean, according to Health Minister Dzulkefly Ahmad. The initiative seeks to enhance the region's capability to manufacture and distribute critical medicines domestically, reducing dependency on international suppliers.

Dzulkefly outlined Malaysia's commitment to spearheading collaborative efforts among Asean member states to develop robust local pharmaceutical production infrastructure. The strategy encompasses strengthening regulatory frameworks, facilitating knowledge-sharing, and coordinating investment in domestic manufacturing facilities across the region.

The move reflects growing recognition within Asean of the need for greater pharmaceutical autonomy, particularly in light of global supply chain vulnerabilities highlighted by recent health crises. By pooling resources and expertise, member states aim to ensure more equitable access to essential medicines at affordable prices.

Malaysia's advocacy comes as Asean nations seek to build resilience in their healthcare systems. Officials believe that enhanced regional capacity for pharmaceutical production will better position the bloc to respond to future health emergencies and reduce healthcare costs for member populations.